Following Russel Ross [1], there is now general agreement that vessel wall inflammation
constitutes a major factor in the development of atherosclerosis, atheroma instability and …

Abstract Annexin A5 (A5) forms 2-dimensional crystals over phospholipid bilayers, blocking
their availability for coagulation reactions. Recently, human antiphospholipid (aPL) …

Catastrophic antiphospholipid syndrome is a rapidly progressive life-threatening disease
that causes multiple organ thromboses and dysfunction in the presence of antiphospholipid …

Objective—The cause of the exceedingly high risk of atherothrombosis in systemic lupus
erythematosus (SLE) is not clear but antiphospholipid antibodies (aPL) and potentially …

Antiphospholipid antibodies (aPLs) are acquired antibodies (immunoglobulin [Ig] G, IgM,
and/or IgA isotypes) that react against negatively charged phospholipids. They were …

Objectives. To describe how certain peripheral immune parameters reflect the inflammatory
alterations in patients with primary APS. Methods. Twenty-eight patients with newly …

Not all the cryptocurrencies that exist now are actual a number of the human beings are the
usage of the concept of cryptocurrency to dedicate the acts of fraud. In an occasion of fraud …

Complement plays a major role in inflammation and thrombosis associated with systemic
lupus erythematosus (SLE) and the antiphospholipid syndrome (APS). A cross-sectional …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by recurrent
arterial or venous thrombosis and/or pregnancy losses, in the presence of persistently …

Antiphospholipid antibodies (aPLs) are acquired antibodies directed against negatively
charged phospholipids, a group of inner and outer cell membrane antigens found in …